Sanofi's Rotavirus vaccine enters late-stage trials
PARIS (Reuters) - French drugmaker Sanofi said on Tuesday an investigational vaccine designed by its Shantha Biotechnics unit to protect young children from severe diarrhea had entered late-stage clinical trials in India.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Biotechnology | Children | Clinical Trials | Health | Rotavirus | Rotavirus Vaccine | Vaccines